{"summary":"Sou um profissional com um background cient\u00edfico bastante s\u00f3lido, com doutorado e p\u00f3s-doutorado na \u00e1rea de Onco-Hematologia, compreendendo 9 anos de dedica\u00e7\u00e3o a essa \u00e1rea terap\u00eautica. Al\u00e9m disso, tamb\u00e9m possuo ampla experi\u00eancia na \u00e1rea de pesquisa cl\u00ednica, onde tive a chance de atuar como coordenador de pesquisa por cerca de 3 anos, conduzindo ensaios cl\u00ednicos de fase 3 em diferentes \u00e1reas terap\u00eauticas como Oftalmologia, Psiquiatria, Oncologia Pedi\u00e1trica e Cardiologia. Nos \u00faltimos 6 anos, tenho me dedicado \u00e0 \u00e1rea de Medical Affairs da ind\u00fastria farmac\u00eautica, focado em doen\u00e7as neurol\u00f3gicas e oncol\u00f3gicas, com experi\u00eancia em trabalhar com medicamentos de alto custo em fase pr\u00e9-lan\u00e7amento, lan\u00e7amento e p\u00f3s-lan\u00e7amento. Trabalhei por 4 anos como Medical Science Laision (Esclerose M\u00faltipla e Doen\u00e7a de Alzheimer) e ocupei por seis meses a fun\u00e7\u00e3o de Diagnostic Lead em Doen\u00e7a de Alzheimer na Biogen. Atualmente, trabalho como Senior Medical Manager em Oncologia na Gilead, onde sou respons\u00e1vel pela estrat\u00e9gia m\u00e9dica da empresa para C\u00e2ncer de Mama e gerencio o time de MSLs.\n\nEm rela\u00e7\u00e3o \u00e0s softs skills, possuo uma comunica\u00e7\u00e3o oral e escrita bastante clara e assertiva, racioc\u00ednio estrat\u00e9gico e tenho facilidade em aprender novas atividades e habilidades. Al\u00e9m disso, prezo muito pelo trabalho colaborativo e cross-functional, al\u00e9m de demostrar bastante resili\u00eancia e adaptabilidade \u00e0s mudan\u00e7as e desafios.","lastName":"Carlini Fernando, PhD","objectUrn":"urn:li:member:242717985","geoRegion":"S\u00e3o Paulo, S\u00e3o Paulo, Brazil","fullName":"Rodrigo Carlini Fernando, PhD","firstName":"Rodrigo","currentPositions":[{"companyName":"Gilead Sciences","title":"Senior Medical Manager - Breast Cancer","tenureAtCompany":{"numYears":2,"numMonths":1},"companyUrnResolutionResult":{"website":"http:\/\/www.gilead.com","formattedRevenue":{"unit":"BILLION","amount":26.1,"currencyCode":"USD"},"industry":"Biotechnology Research","employeeCountRange":"10001+","headquarters":{"geographicArea":"CA","country":"United States","city":"Foster City","postalCode":"94404","line1":"333 Lakeside Drive"},"revenue":{"amount":"26107000000","currencyCode":"USD"},"flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/gilead-sciences\/"},"startedOn":{"month":1,"year":2024},"companyUrn":"urn:li:fs_salesCompany:163993"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAA53lSEB2uVJGFGUJNgtbjbiQA3bRLJZ2FQ,NAME_SEARCH,oqxz)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1645123014519?e=1723075200&v=beta&t=NljqLOTKsuH4gdtFvS76VIPhihyj0QFV3H8zjOBEdJ4","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1645123014519?e=1723075200&v=beta&t=dot6_-KcjhYTh5oeyGo7r35rcxdkiltsnNxYb9WkcUo","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1645123014519?e=1723075200&v=beta&t=uo7_Luw0teJ-qI-G75rEmrLHSW3eHFm36zW4puWCtbA","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1645123014519?e=1723075200&v=beta&t=1GRsTja9j0g_AmLwu0HgxVZmWhCzz4NX6okNVMZ1uwY","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C4D03AQGy5JkLX86M_g\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Pharmaceutical Manufacturing","educations":[{"endedOn":{"month":4,"year":2021},"degree":"P\u00f3s-doutorado","eduId":726477671,"schoolUrn":"urn:li:fs_salesSchool:33457","school":"urn:li:fs_salesSchool:33457","fieldsOfStudy":["Hematologia"],"schoolName":"Unifesp - Universidade Federal de S\u00e3o Paulo","startedOn":{"month":3,"year":2019}},{"endedOn":{"year":2017},"degree":"Doutorado","eduId":234360077,"schoolUrn":"urn:li:fs_salesSchool:33457","school":"urn:li:fs_salesSchool:33457","fieldsOfStudy":["Hematologia"],"schoolName":"Universidade Federal de S\u00e3o Paulo","startedOn":{"year":2014}},{"endedOn":{"year":2013},"degree":"Bacharelado em Ci\u00eancias Biol\u00f3gicas - Modalidade M\u00e9dica","eduId":152188802,"schoolUrn":"urn:li:fs_salesSchool:33457","school":"urn:li:fs_salesSchool:33457","fieldsOfStudy":["Biologia Molecular"],"schoolName":"Universidade Federal de S\u00e3o Paulo","startedOn":{"year":2010}},{"endedOn":{"month":10,"year":2024},"degree":"Executive MBA","eduId":912411920,"schoolUrn":"urn:li:fs_salesSchool:8175","school":"urn:li:fs_salesSchool:8175","fieldsOfStudy":["Gest\u00e3o com \u00eanfase em Lideran\u00e7a e Inova\u00e7\u00e3o"],"schoolName":"Funda\u00e7\u00e3o Getulio Vargas","startedOn":{"month":8,"year":2023}}],"skills":[{"numOfEndorsement":4,"name":"Medical affairs"},{"numOfEndorsement":5,"name":"Clinical Research"},{"numOfEndorsement":2,"name":"Pharmaceutical Industry"},{"numOfEndorsement":6,"name":"Investiga\u00e7\u00f5es cl\u00ednicas"},{"numOfEndorsement":9,"name":"Research"},{"numOfEndorsement":3,"name":"Pesquisa"},{"numOfEndorsement":1,"name":"Pesquisa Cl\u00ednica"},{"numOfEndorsement":1,"name":"Neuroci\u00eancia"},{"numOfEndorsement":1,"name":"Neurologia"},{"numOfEndorsement":0,"name":"Oncologia"},{"numOfEndorsement":0,"name":"Hematologia"},{"numOfEndorsement":0,"name":"Ind\u00fastria farmac\u00eautica"},{"numOfEndorsement":0,"name":"Ensaios cl\u00ednicos"},{"numOfEndorsement":2,"name":"Microsoft Office"},{"numOfEndorsement":1,"name":"Microsoft Excel"},{"numOfEndorsement":0,"name":"Microsoft PowerPoint"},{"numOfEndorsement":0,"name":"Microsoft Word"},{"numOfEndorsement":2,"name":"Ingl\u00eas"},{"numOfEndorsement":1,"name":"Good Clinical Practice"},{"numOfEndorsement":1,"name":"Anvisa"},{"numOfEndorsement":1,"name":"Onco-Hematologia"},{"numOfEndorsement":0,"name":"GCP\/ICH"},{"numOfEndorsement":0,"name":"Sistema CEP\/Conep"},{"numOfEndorsement":0,"name":"Scientific Research"},{"numOfEndorsement":0,"name":"Lideran\u00e7a"},{"numOfEndorsement":0,"name":"Desenvolvimento pessoal"},{"numOfEndorsement":0,"name":"Vis\u00e3o estrat\u00e9gica"},{"numOfEndorsement":0,"name":"Colabora\u00e7\u00e3o em v\u00e1rias fun\u00e7\u00f5es"},{"numOfEndorsement":1,"name":"Trabalho em equipe"},{"numOfEndorsement":0,"name":"Comunica\u00e7\u00e3o oral"},{"numOfEndorsement":0,"name":"Comunica\u00e7\u00e3o escrita"},{"numOfEndorsement":1,"name":"Lan\u00e7amento de produtos"},{"numOfEndorsement":0,"name":"Relacionamentos interpessoais"},{"numOfEndorsement":0,"name":"Gest\u00e3o de relacionamento com o cliente (CRM)"},{"numOfEndorsement":0,"name":"Clinical research"},{"numOfEndorsement":0,"name":"Planejamento estrat\u00e9gico"},{"numOfEndorsement":0,"name":"Gest\u00e3o de tempo"},{"numOfEndorsement":0,"name":"Assuntos m\u00e9dicos"},{"numOfEndorsement":0,"name":"Intelig\u00eancia emocional"},{"numOfEndorsement":0,"name":"Feedback construtivo"}],"numOfConnections":3284,"patents":[],"headline":"Sr Medical Manager | Oncology","courses":[{"name":"Estat\u00edstica Aplicada \u00e0 Psicobiologia - N\u00edvel I","number":""},{"name":"Estat\u00edstica Aplicada \u00e0 Psicobiologia - N\u00edvel II","number":""},{"name":"Good Clinical Practice - NIDA Clinical Trial Network","number":""},{"name":"Princ\u00edpios \u00c9ticos em Pesquisa Cient\u00edfica","number":""}],"certifications":[{"authority":"Invitare Pesquisa Cl\u00ednica ","name":"Forma\u00e7\u00e3o Profissional em Pesquisa Clinica ","company":"urn:li:fs_salesCompany:27008284","startedOn":{"month":12,"year":2014},"companyUrn":"urn:li:fs_salesCompany:27008284"},{"authority":"SBPNL - Sociedade Brasileira de PNL","name":"Practitioner em PNL","company":"urn:li:fs_salesCompany:4815337","startedOn":{"month":10,"year":2017},"companyUrn":"urn:li:fs_salesCompany:4815337"},{"authority":"SBPNL - Sociedade Brasileira de PNL","name":"Master Practitioner em PNL","company":"urn:li:fs_salesCompany:4815337","startedOn":{"month":10,"year":2019},"companyUrn":"urn:li:fs_salesCompany:4815337"},{"authority":"Escola Conquer","name":"Intelig\u00eancia Emocional ","company":"urn:li:fs_salesCompany:10845982","startedOn":{"month":5,"year":2021},"companyUrn":"urn:li:fs_salesCompany:10845982"},{"companyUrn":"urn:li:fs_salesCompany:1337","url":"https:\/\/www.linkedin.com\/learning\/certificates\/b5ce0fec68d91f91fafc05e3a9d096206527e5df6e064f5982eae0ae44e10263?trk=backfilled_certificate","authority":"LinkedIn","name":"Como Gerenciar Relacionamentos com seu Chefe, Colegas e Subordinados","company":"urn:li:fs_salesCompany:1337","startedOn":{"month":5,"year":2021}},{"companyUrn":"urn:li:fs_salesCompany:1337","url":"https:\/\/www.linkedin.com\/learning\/certificates\/89764702e31e2449c0a71242c3048a39eaae71f20447f1612ee8f63fa61ac20d","authority":"LinkedIn","name":"Como Desenvolver sua Intelig\u00eancia Emocional","company":"urn:li:fs_salesCompany:1337","startedOn":{"month":3,"year":2022}},{"companyUrn":"urn:li:fs_salesCompany:1337","url":"https:\/\/www.linkedin.com\/learning\/certificates\/907ab1630636914eb9bbd3034dacfcc6122f1806828186f7d1100971bddde540","authority":"LinkedIn","name":"Como Dar e Receber Feedback","company":"urn:li:fs_salesCompany:1337","startedOn":{"month":3,"year":2022}}],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/rodrigocfernando","organizations":[],"location":"S\u00e3o Paulo, S\u00e3o Paulo, Brazil","publications":[{"name":"Multiple myeloma cell lines and primary tumors proteoma: protein biosynthesis and immune system as potential therapeutic targets","publishedOn":{"month":11,"day":24,"year":2015},"publisher":"Genes & Cancer","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAA53lSEB2uVJGFGUJNgtbjbiQA3bRLJZ2FQ,NAME_SEARCH,oqxz)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdKMQkBfq2ZO1KJBF7si_WrDvaWVBTozaE,NAME_SEARCH,gEYZ)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAatsNUBpU3XEeCYYBUovouHVREaCIUpVeg,NAME_SEARCH,SfGH)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAmDRAMBiiT0KCQVMdlieib3qd8ENTS6nJ0,NAME_SEARCH,L90u)"}]},{"name":"Serum free light chains and post-transplant lymphoproliferative disorder in patients with renal transplant.","publishedOn":{"month":3,"day":4,"year":2013},"publisher":"Leukemia & Lymphoma","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23398208","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAA53lSEB2uVJGFGUJNgtbjbiQA3bRLJZ2FQ,NAME_SEARCH,oqxz)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAASkpZQBA89QS1xjet0E4C17JEXcv5TZ_VE,NAME_SEARCH,ChW3)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAA577A8BRIESFX_2nfA2dcyzQ1DuWyPjU1I,NAME_SEARCH,VwYV)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAACFJIBIBO4WSgqTfiUJ1uLvDOWVfjr3bKWE,NAME_SEARCH,ceSO)"}]},{"name":"Anti-myeloma effects of ruxolitinib combined with bortezomib and lenalidomide: A rationale for JAK\/STAT pathway inhibition in myeloma patients","publishedOn":{"month":6,"day":20,"year":2017},"publisher":"Cancer letters","url":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28645562","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAA53lSEB2uVJGFGUJNgtbjbiQA3bRLJZ2FQ,NAME_SEARCH,oqxz)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAACFJIBIBO4WSgqTfiUJ1uLvDOWVfjr3bKWE,NAME_SEARCH,ceSO)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAQeKIYBb0Iz90yTTRRGIMloNlnjFqYXkRA,NAME_SEARCH,ntiT)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAA2Kli0BVe2gMjudwAY-vm5pXddihm26e2o,NAME_SEARCH,Js94)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAACKa-4oBU5vbmqT4Wk01EJvM7_cPdIkYn5M,NAME_SEARCH,MsT4)"}]},{"name":"Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma","publishedOn":{"month":12,"day":1,"year":2017},"publisher":"Oncotarget","url":"http:\/\/www.oncotarget.com\/index.php?journal=oncotarget&page=article&op=view&path[]=22815&pubmed-linkout=1","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAA53lSEB2uVJGFGUJNgtbjbiQA3bRLJZ2FQ,NAME_SEARCH,oqxz)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAA2Kli0BVe2gMjudwAY-vm5pXddihm26e2o,NAME_SEARCH,Js94)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAQeKIYBb0Iz90yTTRRGIMloNlnjFqYXkRA,NAME_SEARCH,ntiT)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAACFJIBIBO4WSgqTfiUJ1uLvDOWVfjr3bKWE,NAME_SEARCH,ceSO)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAACKa-4oBU5vbmqT4Wk01EJvM7_cPdIkYn5M,NAME_SEARCH,MsT4)"}]},{"name":"Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism. ","publishedOn":{"month":1,"day":31,"year":2019},"publisher":"Scientific Reports ","url":"https:\/\/www.nature.com\/articles\/s41598-018-38314-8","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAA53lSEB2uVJGFGUJNgtbjbiQA3bRLJZ2FQ,NAME_SEARCH,oqxz)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAatsNUBpU3XEeCYYBUovouHVREaCIUpVeg,NAME_SEARCH,SfGH)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAVEHuIBnxzX5LXhQvNn2-Etg7eh1VsrFhU,NAME_SEARCH,zegL)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAASkpZQBA89QS1xjet0E4C17JEXcv5TZ_VE,NAME_SEARCH,ChW3)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAACFJIBIBO4WSgqTfiUJ1uLvDOWVfjr3bKWE,NAME_SEARCH,ceSO)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAQeKIYBb0Iz90yTTRRGIMloNlnjFqYXkRA,NAME_SEARCH,ntiT)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAA2Kli0BVe2gMjudwAY-vm5pXddihm26e2o,NAME_SEARCH,Js94)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdKMQkBfq2ZO1KJBF7si_WrDvaWVBTozaE,NAME_SEARCH,gEYZ)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAACKa-4oBU5vbmqT4Wk01EJvM7_cPdIkYn5M,NAME_SEARCH,MsT4)"}]},{"name":"Sequential combination of bortezomib and WEE1 inhibitor, MK-1775, induced apoptosis in multiple myeloma cell lines","publishedOn":{"month":9,"day":17,"year":2019},"publisher":"Biochemical and Biophysical Research Communications","url":"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0006291X19316997?via%3Dihub","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAA53lSEB2uVJGFGUJNgtbjbiQA3bRLJZ2FQ,NAME_SEARCH,oqxz)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAACFJIBIBO4WSgqTfiUJ1uLvDOWVfjr3bKWE,NAME_SEARCH,ceSO)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAACKa-4oBU5vbmqT4Wk01EJvM7_cPdIkYn5M,NAME_SEARCH,MsT4)"}]},{"name":"Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma","publishedOn":{"month":3,"day":23,"year":2021},"publisher":"Frontiers in Oncology ","url":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.563384\/full","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAA53lSEB2uVJGFGUJNgtbjbiQA3bRLJZ2FQ,NAME_SEARCH,oqxz)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdKMQkBfq2ZO1KJBF7si_WrDvaWVBTozaE,NAME_SEARCH,gEYZ)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAACKa-4oBU5vbmqT4Wk01EJvM7_cPdIkYn5M,NAME_SEARCH,MsT4)"}]}],"positions":null,"posts":[{"createdAt":1716659700000,"insightId":"bb38b0fb-b51f-4e5d-be38-c3de69c1eb8e","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":11},{"type":"PRAISE","count":3},{"type":"EMPATHY","count":4}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7200192675608686594","threadUrn":"urn:li:ugcPost:7200192675608686594","reactionsCount":18,"commentsCount":1,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7200192675608686594","message":{"attributes":[{"start":237,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:180494890"}}},{"start":252,"length":12,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:635686650"}}},{"start":265,"length":19,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:260852205"}}},{"start":285,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:2269984"}}}],"text":"Manh\u00e3 repleta de discuss\u00f5es super ricas no manejo de pacientes com de c\u00e2ncer de mama, com dois oncologistas que s\u00e3o refer\u00eancia nacional na \u00e1rea de tumores mam\u00e1rios, Dr Sandro e a Dr Guindalini, e ao lado desse time sensacional da Gilead Juliana Cacure Leila Moraes Marcela Vasconcelos Paola Franchin"},"rootActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:multiPhoto:1000187519537"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7200164628994134016","message":{"attributes":[{"length":29,"start":179,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:633065977"}}},{"length":16,"start":212,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:59652350"}}},{"length":19,"start":262,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:260852205"}}},{"length":12,"start":283,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:635686650"}}},{"length":29,"start":297,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:242717985"}}},{"length":14,"start":328,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:2269984"}}},{"length":8,"start":344,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:914586121"}}},{"length":12,"start":355,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:333088315"}}},{"length":11,"start":370,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:87787266"}}},{"length":22,"start":384,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:411519562"}}},{"length":15,"start":409,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:110117206"}}},{"length":15,"start":426,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:14016981"}}},{"length":17,"start":567,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:creatingpossible"}}},{"length":15,"start":585,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:gileadoncology"}}}],"text":"Que energia boa nesse s\u00e1bado em Bel\u00e9m, Par\u00e1.\n\nMuito bom poder reunir 50 especialistas para discuss\u00e3o pr\u00e1tica do cuidado no c\u00e2ncer de mama metast\u00e1tico.\n\nObrigada aos especialistas Rodrigo Santa Cruz Guindalini  e Sandro Cavallero por esse encontro t\u00e3o especial.\n\nMarcela Vasconcelos, Leila Moraes, Rodrigo Carlini Fernando, PhD, Paola Franchin, Luana A. , Esther Sahid , Keli Ubaldo , Felipe Feistauer, M.Sc , Eduardo Almeida, Maezono, Renata \u2026 foi lindo! Juntos somos sempre melhores \u2764\ufe0f\n\nVamos em frente com nosso foco de trazer mais vida para pacientes com c\u00e2ncer.\n\n#CreatingPossible #GileadOncology"},"entityUrn":"urn:li:ugcPost:7200164628994134016"},"entityUrn":"urn:li:ugcPost:7200192675608686594"}}},{"createdAt":1711053600000,"insightId":"8946cdf5-facb-4bfb-9c4d-cff840b68ea4","activityUnion":{"postActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D4D22AQEE_YW27hy4ww\/feedshare-shrink_2048_1536\/0\/1711053625128?e=1720051200&v=beta&t=JLXsXl61Q9U4k-qmrunxyDQf3idYHTJJKngJ3MnwNYI"}},"socialMetadata":{"reactionTypeCounts":[{"type":"PRAISE","count":7},{"type":"APPRECIATION","count":1},{"type":"LIKE","count":53},{"type":"EMPATHY","count":1},{"type":"INTEREST","count":3}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7176679070359830528","threadUrn":"urn:li:activity:7176679070359830528","reactionsCount":65,"commentsCount":3,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7176679069638344704","message":{"attributes":[],"text":"Conclui hoje a leitura do meu primeiro livro do ano \u201cNa\u00e7\u00e3o dopamina\u201d (abaixo da meta de ler um livro por m\u00eas como havia proposto para mim mesmo no in\u00edcio do ano, mas vamos deixar isso pra l\u00e1 rs). \n\nMuitas pessoas t\u00eam pavor de livros de desenvolvimento pessoal ou \u201cauto-ajuda\u201d. Sei que alguns acabam sendo descolados da realidade, mas confesso que esse \u00e9 o meu g\u00eanero favorito e j\u00e1 tirei muitos ensinamentos importantes de livros como esse que conclui hoje.  \n\nNesse livro, a autora Dra. Anna Lembke, m\u00e9dica psiquiatra e professora da Universidade de Stanford,  explora como vivemos, atualmente, em um era de excessos, em que somos expostos diariamente a est\u00edmulos de alta dopamina e, com isso, com potencial de causar depend\u00eancia e prejudicar a nossa vida e a das pessoas que amamos. Essa fuga do sofrimento a todo custo \u00e9 busca exagerada pelo prazer imediato, acaba causando um desequil\u00edbrio na balan\u00e7a de prazer-sofrimento e, com isso, gera mais sofrimento no m\u00e9dio e longo prazo.\n\nAo longo livro, ela traz diversos casos de pacientes que ela atendeu, com os mais diversas tipos de depend\u00eancias, e as estrat\u00e9gias que eles utilizaram para controlar isso e viver uma vida mais equilibrada e feliz.\n\nRecomendo a leitura."},"entityUrn":"urn:li:share:7176679069638344704"}}},{"createdAt":1710943440000,"insightId":"5704a08a-8e66-4ab5-8697-d34d46484830","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":15},{"type":"PRAISE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7176217004888973312","threadUrn":"urn:li:activity:7176217004888973312","reactionsCount":16,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7176217004456960000","message":{"attributes":[],"text":"Oportunidade bem bacana para fazer parte do time de Oncologia da Gilead."},"rootActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4D27AQGErBb47aMwLQ\/articleshare-shrink_800\/0\/1716993748091?e=1717977600&v=beta&t=2E3yAModDckSwuQSe9TCohXmR9TKWaLqqEZjh0tnpkU","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4D27AQGErBb47aMwLQ\/articleshare-shrink_800\/0\/1716993748091?e=1717977600&v=beta&t=2E3yAModDckSwuQSe9TCohXmR9TKWaLqqEZjh0tnpkU"}]},"description":"For Current Gilead Employees and Contractors: Please log onto your Internal Career Site to apply for this job. At Gilead, we\u2019re creating a healthier world for all people. For more than 35 years, we\u2019ve tackled diseases such as HIV, viral hepatitis,...","fullText":"For Current Gilead Employees and Contractors: Please log onto your Internal Career Site to apply for this job. At Gilead, we\u2019re creating a healthier world for all people. For more than 35 years, we\u2019ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer \u2013 working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world\u2019s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. We empower our leaders to step up, share ideas, listen, learn, and lead. We\u2019re welcoming bright, diverse, and imaginative minds; we\u2019re nurturing them to foster an environment of inclusion and growth where innovation is encouraged. We expect our people leaders to model that environment, and to focus on creating inclusion, developing talent, and enabling teams. Every member of Gilead\u2019s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we\u2019re looking for the next wave of passionate and ambitious people ready to make a direct impact. Join Gilead and help create possible, together. Job Description Gilead Sciences Inc. is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries world-wide, with headquarters in Foster City, California, USA. In 2020, Gilead completed the acquisition of a number of companies which are developing innovative treatments in the field of oncology. One of the leading compounds is a novel Antibody Drug Conjugate (ADC), which is being investigated for its potential application across various types of cancer, initially metastatic Triple Negative Breast Cancer (mTNBC) where there is a significant unmet medical need. Due to the anticipated regulatory authorisation of this new ADC in 2021, we are currently in the process of building a new sales team across Germany and are looking for Therapeutic Specialists to join our new Oncology Business Unit in these key territories. In this role you will be one of the key contributors in our new oncology franchise, providing patients and healthcare professionals access to this innovative treatment. The focus will be on oncology physicians who treat patients with mTNBC. Our Therapeutic Specialists across all our existing therapy areas are enthusiastic about our patient-centric approach and expert in discussing and explaining the characteristics and benefits of our treatment(s) in a highly scientific and dynamic healthcare environment. Specific responsibilities \u2022 Prepare business plan for your territory aligned to local cancer alliance priorities for mTNBC, communicate required actions to achieve goals. With guidance, initiate systems to monitor sales progress and action plans. \u2022 Responsible for identifying and mapping out patient referral pathways within the cancer alliances on your territory and facilitating patient access to treatment. \u2022 Responsible for achieving sales targets in assigned territory. \u2022 Responsible for working in partnership with Regional Market Access, Medical and Customer Network Manager colleagues to ensure local access is in place for Gilead medicines. \u2022 Establish and develop business relationships with key customers, accounts and relevant key opinion leaders. Responsible for setting and achieving customer contact plans and delivering on related KPIs. \u2022 Manage territory budgets for customer contacts, speaker events and other miscellaneous external expenditures. \u2022 May represent company at professional events and promote company products at such events. \u2022 Work co-operatively with Gilead Medical Scientists, National Account Managers, Marketing and Market Access on various cross-functional projects. \u2022 Assist in the identification and resolution of issues and opportunities, communicate proactively to Marketing and Sales management. \u2022 Complete necessary administrative tasks in a timely manner e.g. updating customer database, expenses, etc. \u2022 Responsible for achieving the competency levels required in the role. \u2022 Compliance with country regulations and code of conduct at all times. \u2022 Role will require travel and depending on location the need for overnight stays. Knowledge, experience and skills \u2022 The ideal candidate will have a passion for commercializing this breakthrough medicine, a strong competitive and commercial mindset, robust scientific acumen and a patient centric approach. \u2022 Experience in an oncology specialist therapy area is required \u2022 Prior experience (5+ years) with solid tumors and especially in the therapeutic field of breast cancer is strongly preferred \u2022 The ideal candidate has established contacts to relevant customers \u2022 Excellent understanding of relevant targeted therapies and personalized medicines based on different biomarkers is critical. \u2022 Must have sound scientific expert knowledge and be able to stay on top of all relevant new emerging data \u2022 Must be able to understand and digest original publications and talks \u2022 Must be able to demonstrate a thorough understanding of how cancer services are delivered. \u2022 Must have strong interpersonal skills with the ability to lead and build working relationships internally and externally. \u2022 Must be able to develop strong relationships with key opinion leaders and communicate on eye level. \u2022 Must have proven expertise in building interpersonal relationships, along with strong influencing and negotiating skills. \u2022 Must have proven experience in account planning and cross-functional account management approach. \u2022 Must be self-motivated and able to work with a general level of autonomy and independence. \u2022 Must be familiar with industry trends and remain current with competitors' resources and practices. \u2022 Must demonstrate solid analytical skills, be able to identify and understand moderate to complex issues, problems and interpret information in a manner that provides appropriate recommendations to management and specialists. \u2022 Must be able to work in cross-functional teams. \u2022 Pharmareferentenausbildung (or equivalent qualifikation through academic studies) \u2022 Must be a Portuguese native speaker with fluent English skills (written and spoken) Location Campinas, SP Desired behaviours \u2022 Resilient and able to handle emotional stress \u2022 Strong commercial acumen with the ability to deliver in a very competitive environment. \u2022 Operational excellence. \u2022 Analytical with systematic approach to prioritization. \u2022 Strong team player and cross functional approach. \u2022 Curious, with learning agility. Gilead commercial competencies \u2022 Initiative into action. \u2022 Strategic approach. \u2022 Communications impact and influence. \u2022 Customer relationship building. \u2022 Customer and market insights. \u2022 Business analytics. Gilead core values \u2022 Integrity (doing what's right) \u2022 Teamwork (working together) \u2022 Excellence (being your best) \u2022 Accountability (taking personal responsibility) \u2022 Inclusion (encouraging diversity) For Current Gilead Employees and Contractors: Please log onto your Internal Career Site to apply for this job. Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.","resolvedUrl":"https:\/\/gilead.wd1.myworkdayjobs.com\/gileadcareers\/job\/Brazil---Sao-Paulo\/Therapeutic-Specialist---Campinas_R0040253","title":"Therapeutic Specialist - Campinas","sourceDomain":"gilead.wd1.myworkdayjobs.com"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7176181218164547584","message":{"attributes":[{"start":106,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/dnxzKEwq"}}}],"text":"Temos uma excelente oportunidade para quem quer deixar um legado na ind\u00fastria farmac\u00eautica brasileira!\n\n\n\nhttps:\/\/lnkd.in\/dnxzKEwq\n\u00a0"},"entityUrn":"urn:li:share:7176181218164547584"},"entityUrn":"urn:li:share:7176217004456960000"}}},{"createdAt":1710420060000,"insightId":"e8da75aa-270b-4c0c-bdec-3a0ce7ebf23e","activityUnion":{"postActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:multiPhoto:1000141599986"}},"socialMetadata":{"reactionTypeCounts":[{"type":"PRAISE","count":56},{"type":"LIKE","count":109},{"type":"EMPATHY","count":26},{"type":"INTEREST","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7174021832654606336","threadUrn":"urn:li:ugcPost:7174021832654606336","reactionsCount":192,"commentsCount":50,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7174021832654606336","message":{"attributes":[{"length":14,"start":16,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:180494890"}}},{"length":14,"start":717,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:180494890"}}},{"length":18,"start":738,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:832814"}}}],"text":"Nessa semana, a Juliana Cacure  e eu tivemos a honra e o orgulho de representar o a Brasil e a Oncologia da Gilead na 3a edi\u00e7\u00e3o do Global Commercial and Medical Innovation Tournament, em Foster City. \n\nTer a chance de apresentar o nosso projeto - Gilead OncoCast - para grandes lideran\u00e7as globais da companhia foi uma experi\u00eancia inexplic\u00e1vel. Dentre os 174 projetos submetidos, provenientes de 29 pa\u00edses, estar entre os 5 melhores \u00e9 motivo de muito alegria para todos n\u00f3s. \n\nAl\u00e9m disso, tamb\u00e9m foi muito bom  poder assistir \u00e0s apresenta\u00e7\u00f5es dos colegas de outras afiliadas sobre os seus projetos inovadores. \n\nObviamente que o OncoCast foi constru\u00eddo a muitas m\u00e3os, mas gostaria de fazer um agradecimento especial \u00e0 Juliana Cacure  e ao Reinaldo Capezzuto, que desde a primeira conversa sobre esse iniciativa, abra\u00e7aram a ideia e n\u00e3o pouparam esfor\u00e7os para faz\u00ea-la se tornar realidade."},"entityUrn":"urn:li:ugcPost:7174021832654606336"}}},{"createdAt":1716655260000,"insightId":"78655215-9a6c-4280-bfb7-9ca50a0eaff1","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1},{"type":"EMPATHY","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7200164628994134016,7200174197287841792)","threadUrn":"urn:li:ugcPost:7200164628994134016","reactionsCount":3,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Evento excelente, ,com aulas brilhantes e lado de um time sensacional como voc\u00eas."},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7200164628994134016"}}},{"createdAt":1716051300000,"insightId":"4f5458e4-f1b4-493c-95e2-f8f08c523dd2","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1},{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7197631812905394176,7197641062486593536)","threadUrn":"urn:li:ugcPost:7197631812905394176","reactionsCount":2,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Parab\u00e9ns, Lipe! Evento incr\u00edvel com uma discuss\u00e3o muito rica sobre ADCs e CAR-T."},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7197631812905394176"}}},{"createdAt":1713176580000,"insightId":"0a137cb9-2b4b-4109-8822-323fbef3d9b5","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7185405661596291072,7185583428635901952)","threadUrn":"urn:li:activity:7185405661596291072","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Parab\u00e9ns, meu amigo!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7185405661596291072"}}},{"createdAt":1711101300000,"insightId":"239d5fa6-9c50-476d-9531-2f725a937e18","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7176764557518905344,7176879154028494848)","threadUrn":"urn:li:ugcPost:7176764557518905344","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Parab\u00e9ns, minha amiga! Ainda mais sucesso e alegrias nesse novo ciclo!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7176764557518905344"}}},{"createdAt":1710951420000,"insightId":"96f4340c-3596-418a-8d9f-7a74527dd98b","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"EMPATHY","count":2},{"type":"PRAISE","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7176233653125980160,7176250626018795520)","threadUrn":"urn:li:ugcPost:7176233653125980160","reactionsCount":4,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Seja muito bem-vindo, Paiva! Ganha a Gilead com um excelente profissional e pessoa como voc\u00ea!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7176233653125980160"}}},{"createdAt":1710683820000,"insightId":"2d6de39b-e8ec-4142-8c1b-f94a1446671d","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7174021832654606336,7175128070998155264)","threadUrn":"urn:li:ugcPost:7174021832654606336","reactionsCount":2,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Rei, n\u00e3o canso de agradecer por toda a pareceria, trabalho colaborativo e vontade de buscar solu\u00e7\u00f5es quando eventualmente nos deparamos com desafios pelo caminho. O privilegio \u00e9 meu de poder trabalhar ao lado de pessoas e profissionais como voc\u00eas. E refor\u00e7ando as palavras suas e da Ju, ter esse prop\u00f3sito de levar educa\u00e7\u00e3o m\u00e9dica da para a comunidade m\u00e9dica brasileira \u00e9 algo que nos d\u00e1 muito orgulho e esses resultados s\u00e3o consequ\u00eancia disso. Que venham muitos projetos como esse pela frente."},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7174021832654606336"}}},{"createdAt":1710683640000,"insightId":"b833086a-093d-417b-8afd-5703ec28cefb","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7174021832654606336,7175127410697191424)","threadUrn":"urn:li:ugcPost:7174021832654606336","reactionsCount":2,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Juu, tem sido um privil\u00e9gio trabalhar ao lado de pessoas com prop\u00f3sitos t\u00e3o bonitos como voc\u00eas, compet\u00eancia t\u00e9cnica indiscut\u00edvel e, o mais importante, com um cora\u00e7\u00e3o enorme e sempre dispon\u00edveis para ajudar e colaborar. Vamos que esse ano ainda tem muita coisa pela frente!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7174021832654606336"}}},{"createdAt":1710683400000,"insightId":"c80864f4-ff75-40f3-8c18-267b79d810f9","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7174021832654606336,7175126256177266689)","threadUrn":"urn:li:ugcPost:7174021832654606336","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Muito obrigado pelo carinho, suporte e torcida, Mai!!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7174021832654606336"}}},{"createdAt":1710683400000,"insightId":"29de6e9f-132a-4314-9032-631e4e3ba51f","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7174021832654606336,7175126419042091008)","threadUrn":"urn:li:ugcPost:7174021832654606336","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Muito obrigado pelo carinho, minha amiga! O Rei \u00e9 fera e \u00e9 um privil\u00e9gio poder trabalhar com ele!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7174021832654606336"}}},{"createdAt":1710683340000,"insightId":"65f86d90-27a9-459c-a1cc-45f10a507f6d","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7174021832654606336,7175126061444198400)","threadUrn":"urn:li:ugcPost:7174021832654606336","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Muito obrigado pelo carinho, minha amiga!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7174021832654606336"}}},{"createdAt":1710683340000,"insightId":"6313ad62-48d4-44f1-acde-60379ddb767e","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7174021832654606336,7175125996973539329)","threadUrn":"urn:li:ugcPost:7174021832654606336","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Muito obrigado, Nicholas!!!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7174021832654606336"}}},{"createdAt":1710683280000,"insightId":"a058c5d4-21a1-42a8-9f0f-246a974fdb19","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7174021832654606336,7175125825183244289)","threadUrn":"urn:li:ugcPost:7174021832654606336","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Muito obrigado, meu amigo!!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7174021832654606336"}}},{"createdAt":1710683280000,"insightId":"e15dd155-03dd-44e2-a009-038773c9fe77","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7174021832654606336,7175125928858009600)","threadUrn":"urn:li:ugcPost:7174021832654606336","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Muito obrigado pelo carinho, Cadu!!!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7174021832654606336"}}},{"createdAt":1710683220000,"insightId":"b1bcf7d6-d3d8-4498-9ce1-1082999db90d","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7174021832654606336,7175125697797971968)","threadUrn":"urn:li:ugcPost:7174021832654606336","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Muito obrigado pelo carinho, Mariana!!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7174021832654606336"}}},{"createdAt":1710683220000,"insightId":"de205e85-3d56-455d-852c-0257ab0c9a72","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7174021832654606336,7175125598665654272)","threadUrn":"urn:li:ugcPost:7174021832654606336","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Muito obrigado, Dra Bruna!!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7174021832654606336"}}},{"createdAt":1710683220000,"insightId":"c29fc150-7360-48e1-b573-5b387186a06f","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7174021832654606336,7175125501437480960)","threadUrn":"urn:li:ugcPost:7174021832654606336","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Muito obrigado, Bia!!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7174021832654606336"}}}]}